Cosmo shareholders approved all resolutions proposed by the Board of Directors at Extraordinary General Meeting

· Cosmo Pharmaceuticals NV

Cosmo shareholders today approved all resolutions proposed by the Board of Directors at an Extraordinary General Meeting of the Company. A total of 7,173,931 ordinary shares of the share capital of Cosmo were represented at this general meeting of shareholders constituting 40.89% of the total outstanding ordinary shares in the share capital of Cosmo as of the record date.

– Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of 90% versus last year
– Shareholders approved all other proposals of the Board of Directors, including the adoption of the FY2023 annual accounts and updates to the remuneration policy of the Company

Download press release (PDF)

← All news